Name: Latest research reports of Ajanta Pharma Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Ajanta Pharma Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Mid-range Performer

2544.6000 -3.80 (-0.15%)

NSE Sep 19, 2025 15:31 PM

25.77% Fall from 52W High

Volume: 75,435

Ajanta Pharma Ltd.

20 May 2020, 12:00AM

2544.60

-0.15%

Ajanta Pharma (BUY): Near-term growth concerns but demand outlook intact

Buy: Ajanta Pharma Ltd.

BOB Capital Markets Ltd.

Ajanta Pharma (AJP) posted strong Q4 revenue/EBITDA growth of 32%/31% YoY to Rs 6.8bn/Rs 1.7bn.

Number of FII/FPI investors decreased from 385 to 371 in Jun 2025 qtr